Biofrontera Inc.
BFRI· Nasdaq
BFRIBiofrontera Inc.
Filed Apr 11, 2022 · 10-K · 101 days after period end · 0001493152-22-009519
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|
| Revenue | $9.17M | — |
| Net Income | -$14.51M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Apr 11, 2022 · 101 d after period end
